Perspective · 19 Mar 2025
Conference abstractPublished 28 Jul 2016
Irradiated autologous multicellular vaccine isolated from fresh carcinoma induces multiple-target antitumor immunity
Sichuan University, China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: X-irradiated autologous tumor cells with adjuvant have been proved as an effective vaccine which induces reduction of tumor recurrence in some cancer patients but the mechanism remained to be further demonstrated. In a murine model we investigated the composition, efficacy and mechanism of irradiated autologous multicellular vaccine isolated from fresh carcinoma without any manipulations. Material & Method: Single-cell suspensions isolated from tumor tissues were cultured for 24 hours to acquire adherent cells, whose contents were analyzed by flow cytometry. X-irradiated autologous multicellular vaccine (AMCV) or PBS were then injected into mice of protective CT26 and LLC models. Adoptive transfer experiments, depletion of immune cell subsets, 51chromium-release assay, IHC of tumor sections and flow cytometry of spleen and tumor cells were carried out to demonstrate different immune mechanisms. Results & Discussion: AMCV, including tumor cells, epithelial cells, myeloid-derived suppressor cells (MDSCs), provoked protective anti-tumor activity, which was dependent on CD8+ T cells. Compared with PBS group, AMCV not only increased the percentages of CD8+IFN-Ã?³+ and CD4+IFN-Ã?³+ T-cells in spleen and tumor, but also decreased the percentages of MDSCs in spleen. The 51Cr-release assay showed that spleen lymphocytes from mice immunized by AMCV exhibited a higher cytotoxicity against tumor cells, mixed cells derived from carcinoma and endothelial cells (also confirmed in IHC of tumor tissues with CD31). Conclusions: AMCV was able to elicit anti-tumor immunity through multiple target including killing tumor cells and inhibiting angiogenesis, which might be a new strategy for cancer therapy in patients.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.
More from this journal
The newest in Immunotherapy: Open Access.
Perspective · 19 Mar 2025
Advancing Immunotherapy: Future Directions in the Fight against Renal Cell Carcinoma
Short communication · 19 Mar 2025
Emerging Therapies: The Latest Developments in Autoimmune Disease Management
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalImmunotherapy: Open Access
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Chunju Fang”
- BylineArticles whose byline prints “Xiyan Mu”
- BylineArticles whose byline prints “Yuquan Wei”
- BylineArticles whose byline prints “Hanshuo Yang”
